ALFA Finder| Revenue growth | 19.5% YoY for FY26. |
|---|---|
| Margins | EBITDA margin stable at ~36%; PAT margin at 18.6%. |
| Demand visibility | High in Pharma Analytical and Food Testing sectors. |
Growth
FY26 Revenue grew 19.5% YoY to ₹4,163 Mn; PAT increased 16.1% to ₹775 Mn. EBITDA margin stood at 35.8%.
Outlook
FY26 Capex was ₹998 Mn. Focusing on high-growth segments like Electronics and Drug Discovery to leverage global market opportunities.
Risks
Potential impact of new Labour Codes; global economic conditions and currency fluctuations affecting overseas revenue (36% in Pharma).
Earnings Call filed with NSE, NSE: VIMTALABS. Summary written with AI assistance from the document.
Vimta Labs Ltd: key numbers
- Share price
- ₹507.95
- Market cap
- ₹2,271 Cr
- Revenue (annual)
- ₹407.3 Cr
- Net profit (annual)
- ₹77.51 Cr
- P/E (TTM)
- 28.3×Sector 54.5×
- Promoter holding
- 35.64%-0.03% QoQ
- FII holding
- 5.07%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vimta Labs Ltd
All →Vimta Labs Merger & Restructuring Worth ₹0.08 Cr
Vimta Labs incorporated wholly owned US subsidiary Vimta Labs LLC, investing about INR 0.08 Crore (USD 8,500). The contract research unit supports the parent's testing business.
- Value
- ₹0.08 Cr
Vimta Labs Earnings Call Transcript: Key Takeaways
Stable Q2 performance masked by R&D lulls and logistics headwinds.
- Call
- Guides 25% growth
Vimta Labs Results Update
Vimta Labs reported Q2 FY27 income of ₹1,149 Mn, up 9.9% YoY, and PAT of ₹206 Mn at 17.9% margin. EBITDA margins held steady at 35.5%.
Vimta Labs Investor Presentation: Key Takeaways
Q2 FY27: total income Rs1,149Mn (+9.9% YoY), EBITDA Rs408Mn (35.5% margin), PAT Rs206Mn (17.9% margin, +3.5% YoY). H1 FY27 PAT Rs417Mn (+7.3%).
Vimta Labs Q2 FY27 Results: Net Profit ₹20.6 Cr, Up 3.5% YoY
Vimta Labs Ltd reported revenue from operations of ₹112 Cr (+10.0% YoY) and net profit of ₹20.6 Cr (+3.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹20.6 Cr · +3.5% YoY
Vimta Labs Board Meeting Date
Vimta Labs will hold a board meeting on 30 October 2026 to consider half-year results. Trading window stays closed from 01 October.